Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years

This manuscript discloses end-of-study safety data of a community-randomized controlled trial in Finland (NCT00534638), assessing the effectiveness of two vaccination strategies (gender-neutral versus females only) using the AS04-adjuvanted human papillomavirus (HPV)-16/18 (AS04-HPV-16/18) vaccine....

Full description

Saved in:
Bibliographic Details
Main Authors: Dan Bi (Author), Dan Apter (Author), Tiina Eriksson (Author), Mari Hokkanen (Author), Julia Zima (Author), Silvia Damaso (Author), Maaria Soila (Author), Gary Dubin (Author), Matti Lehtinen (Author), Frank Struyf (Author)
Format: Book
Published: Taylor & Francis Group, 2020-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available